{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:54:29Z","timestamp":1781744069149,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific Research Projects Coordination Unit of F\u0131rat University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate serum Visinin-like protein-1 (VILIP-1) levels in normotensive pregnant women and in patients with preeclampsia across the severity spectrum, and to investigate the association between VILIP-1 levels and disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective cross-sectional pilot study, a total of 60 pregnant women were allocated into three groups: normotensive controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920), preeclampsia without severe features (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920), and preeclampsia with severe features (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920). Baseline clinical and laboratory characteristics were recorded. Serum VILIP-1 levels were measured and compared among groups. Statistical analyses were performed using non-parametric tests with adjustment for multiple comparisons.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline demographic and obstetric characteristics were comparable among groups. Gestational age at delivery and neonatal birth weight were significantly lower in the preeclampsia with severe features group. Markers of hepatic and renal dysfunction were significantly elevated in this group, whereas hematological parameters did not differ significantly. Serum VILIP-1 levels were significantly higher in patients with preeclampsia with severe features compared with both normotensive pregnant women and those with preeclampsia without severe features (24.75\u2009\u00b1\u200918.27\u00a0ng\/mL vs. 10.23\u2009\u00b1\u20097.98\u00a0ng\/mL and 7.91\u2009\u00b1\u20094.97\u00a0ng\/mL, respectively; adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum VILIP-1 levels are significantly increased in preeclampsia with severe features and appear to be associated with disease severity and maternal organ involvement. These findings suggest that VILIP-1 may reflect disease severity rather than serving as a diagnostic biomarker; however, larger prospective studies are warranted to clarify its clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09181-3","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:55:49Z","timestamp":1777546549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum visinin-like protein-1 levels in preeclampsia: a cross-sectional pilot study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0437-1700","authenticated-orcid":false,"given":"Neslihan","family":"Aslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2068-7412","authenticated-orcid":false,"given":"Cigdem","family":"Akcabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-0418","authenticated-orcid":false,"given":"Necip","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8085-3703","authenticated-orcid":false,"given":"Miray","family":"Onat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-8264","authenticated-orcid":false,"given":"Ebru Celik","family":"Kavak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-2783","authenticated-orcid":false,"given":"Ibrahim","family":"Batmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6318-5175","authenticated-orcid":false,"given":"Salih Burcin","family":"Kavak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"9181_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130\u20137. https:\/\/doi.org\/10.1053\/j.semperi.2009.02.010.","journal-title":"Semin Perinatol"},{"issue":"1","key":"9181_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","volume":"9","author":"E Dimitriadis","year":"2023","unstructured":"Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, et al. Pre-eclampsia Nat Rev Dis Primers. 2023;9(1):8. https:\/\/doi.org\/10.1038\/s41572-023-00417-6.","journal-title":"Pre-eclampsia Nat Rev Dis Primers"},{"issue":"2","key":"9181_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/HYPERTENSIONAHA.122.19408","volume":"80","author":"C Escudero","year":"2023","unstructured":"Escudero C, Kupka E, Iba\u00f1ez B, Sandoval H, Troncoso F, Wikstr\u00f6m AK, et al. Brain vascular dysfunction in mothers and their children exposed to preeclampsia. Hypertension. 2023;80(2):242\u201356. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.19408.","journal-title":"Hypertension"},{"issue":"5","key":"9181_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/cells11050789","volume":"11","author":"T Friis","year":"2022","unstructured":"Friis T, Wikstr\u00f6m AK, Acurio J, Le\u00f3n J, Zetterberg H, Blennow K, et al. Cerebral biomarkers and blood-brain barrier \u0131ntegrity in preeclampsia. Cells. 2022;11(5):789. https:\/\/doi.org\/10.3390\/cells11050789.","journal-title":"Cells"},{"issue":"3","key":"9181_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrn2093","volume":"8","author":"RD Burgoyne","year":"2007","unstructured":"Burgoyne RD. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci. 2007;8(3):182\u201393. https:\/\/doi.org\/10.1038\/nrn2093.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"9181_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JAD-150060","volume":"47","author":"M Groblewska","year":"2015","unstructured":"Groblewska M, Muszy\u0144ski P, Wojtulewska-Supron A, Kulczy\u0144ska-Przybik A, Mroczko B. The role of visinin-like protein-1 in the pathophysiology of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;47(1):17\u201332. https:\/\/doi.org\/10.3233\/JAD-150060.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"9181_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/brainsci11020215","volume":"11","author":"DA McGrowder","year":"2021","unstructured":"McGrowder DA, Miller F, Vaz K, Nwokocha C, Wilson-Clarke C, Anderson-Cross M, et al. cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: current evidence and future perspectives. Brain Sci. 2021;11(2):215. https:\/\/doi.org\/10.3390\/brainsci11020215.","journal-title":"Brain Sci"},{"issue":"12","key":"9181_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jnnp-2024-333413","volume":"95","author":"F Olde Heuvel","year":"2024","unstructured":"Olde Heuvel F, Li Z, Riedel D, Halbgebauer S, Oeckl P, Mayer B, et al. Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1. J Neurol Neurosurg Psychiatry. 2024;95(12):1158\u201367. https:\/\/doi.org\/10.1136\/jnnp-2024-333413.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9181_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cca.2022.03.008","volume":"531","author":"XJ Yan","year":"2022","unstructured":"Yan XJ, Li YB, Liu W, Dai WM, Wang CL. Predictive value of serum visinin-like protein-1 for early neurologic deterioration and three-month clinical outcome in acute primary basal ganglia hemorrhage: a prospective and observational study. Clin Chim Acta. 2022;531:62\u20137. https:\/\/doi.org\/10.1016\/j.cca.2022.03.008.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"9181_CR10","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237\u201360. https:\/\/doi.org\/10.1097\/AOG.0000000000003891.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"9181_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/HYPERTENSIONAHA.118.11153","volume":"72","author":"E Ciampa","year":"2018","unstructured":"Ciampa E, Li Y, Dillon S, Lecarpentier E, Sorabella L, Libermann TA, et al. Cerebrospinal Fluid Protein Changes in Preeclampsia. Hypertension. 2018;72(1):219\u201326. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11153.","journal-title":"Hypertension"},{"issue":"2","key":"9181_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246786","volume":"16","author":"M Andersson","year":"2021","unstructured":"Andersson M, Oras J, Th\u00f6rn SE, Karlsson O, K\u00e4lebo P, Zetterberg H, et al. Signs of neuroaxonal injury in preeclampsia-A case control study. PLoS ONE. 2021;16(2):e0246786. https:\/\/doi.org\/10.1371\/journal.pone.0246786.","journal-title":"PLoS ONE"},{"key":"9181_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4109","volume":"17","author":"S Basit","year":"2018","unstructured":"Basit S, Wohlfahrt J, Boyd HA. Pre-eclampsia and risk of dementia later in life: nationwide cohort study. BMJ. 2018;17:k4109. https:\/\/doi.org\/10.1136\/bmj.k4109.","journal-title":"BMJ"},{"issue":"1","key":"9181_CR14","doi-asserted-by":"publisher","first-page":"107.e1","DOI":"10.1016\/j.ajog.2018.04.002","volume":"219","author":"LH Theilen","year":"2018","unstructured":"Theilen LH, Meeks H, Fraser A, Esplin MS, Smith KR, Varner MW. Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. Am J Obstet Gynecol. 2018;219(1):107.e1-107.e6. https:\/\/doi.org\/10.1016\/j.ajog.2018.04.002.","journal-title":"Am J Obstet Gynecol"},{"key":"9181_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105742","volume":"116","author":"V Bucher","year":"2025","unstructured":"Bucher V, Herrock OT, Schell S, Visser J, Imberg H, Burke J, et al. Blood-brain barrier injury and neuroinflammation in pre-eclampsia and eclampsia. EBioMedicine. 2025;116:105742. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105742.","journal-title":"EBioMedicine"},{"issue":"1","key":"9181_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1186\/s40001-025-03584-2","volume":"30","author":"HA Atalmis","year":"2025","unstructured":"Atalmis HA, Kulan P, Tekin S, Guler EY, Guleroglu FY, Cim N, et al. Cerebrospinal fluid visinin-like protein, glial cell line-derived neurotrophic factor, and cadherin-6 alterations in pregnancy complications. Eur J Med Res. 2025;30(1):1289. https:\/\/doi.org\/10.1186\/s40001-025-03584-2.","journal-title":"Eur J Med Res"},{"issue":"3","key":"9181_CR17","doi-asserted-by":"publisher","first-page":"269.e1","DOI":"10.1016\/j.ajog.2019.06.024","volume":"221","author":"RM Burwick","year":"2019","unstructured":"Burwick RM, Togioka BM, Speranza RJ, Gaffney JE, Roberts VHJ, Frias AE, et al. Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia. Am J Obstet Gynecol. 2019;221(3):269.e1-269.e8. https:\/\/doi.org\/10.1016\/j.ajog.2019.06.024.","journal-title":"Am J Obstet Gynecol"},{"key":"9181_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/ijgo.70456","volume":"171","author":"R Dayanan","year":"2025","unstructured":"Dayanan R, Bulan DD, Yucel KY. Diagnostic and prognostic role of thrombospondin-4 levels in pre-eclampsia: Association with onset type, severity, and perinatal outcome. Int J Gynecol Obstet. 2025;171:345\u201352. https:\/\/doi.org\/10.1002\/ijgo.70456.","journal-title":"Int J Gynecol Obstet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09181-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:20:26Z","timestamp":1781742026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09181-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9181"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09181-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the F\u0131rat University Faculty of Medicine Local Ethics Committee (Ethics Committee Decision No: 2022\/5\u201310; Session Date: 07.04.2022; Clinical trial number: not applicable.).Written informed consent was obtained from all participants, and all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participation"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"661"}}